US Patent 9126959 PPAR-sparing thiazolidinedione salts for the treatment of metabolic diseases

Patent 9126959 was granted and assigned to Metabolic Solutions Development Company on September, 2015 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

‌

Metabolic Solutions Development Company

Current Assignee

‌

Metabolic Solutions Development Company

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

91269590

Date of Patent

September 8, 2015

Patent Application Number

145281630

Date Filed

October 30, 2014

Patent Primary Examiner

‌

Patricia L Morris

Patent abstract

The present invention relates to novel salts of thiazolidinediones and other pharmaceutical agents that are useful for treating and/or preventing metabolic diseases (e.g., diabetes, or neurodegenerative diseases (e.g., Alzheimer's Disease).

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9126959 PPAR-sparing thiazolidinedione salts for the treatment of metabolic diseases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API